Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Julphar
Fish and Richardson
UBS
Queensland Health
Johnson and Johnson
Cipla
Accenture
Express Scripts
US Department of Justice

Generated: January 20, 2018

DrugPatentWatch Database Preview

PRINIVIL Drug Profile

« Back to Dashboard

When do Prinivil patents expire, and what generic alternatives are available?

Prinivil is a drug marketed by Merck and is included in one NDA.

The generic ingredient in PRINIVIL is lisinopril. There are twenty-one drug master file entries for this compound. Eighty-three suppliers are listed for this compound. Additional details are available on the lisinopril profile page.

US Patents and Regulatory Information for PRINIVIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck PRINIVIL lisinopril TABLET;ORAL 019558-006 Jan 28, 1994 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck PRINIVIL lisinopril TABLET;ORAL 019558-003 Dec 29, 1987 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck PRINIVIL lisinopril TABLET;ORAL 019558-001 Dec 29, 1987 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck PRINIVIL lisinopril TABLET;ORAL 019558-002 Dec 29, 1987 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck PRINIVIL lisinopril TABLET;ORAL 019558-004 Oct 25, 1988 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for PRINIVIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck PRINIVIL lisinopril TABLET;ORAL 019558-004 Oct 25, 1988 ➤ Subscribe ➤ Subscribe
Merck PRINIVIL lisinopril TABLET;ORAL 019558-006 Jan 28, 1994 ➤ Subscribe ➤ Subscribe
Merck PRINIVIL lisinopril TABLET;ORAL 019558-001 Dec 29, 1987 ➤ Subscribe ➤ Subscribe
Merck PRINIVIL lisinopril TABLET;ORAL 019558-003 Dec 29, 1987 ➤ Subscribe ➤ Subscribe
Merck PRINIVIL lisinopril TABLET;ORAL 019558-002 Dec 29, 1987 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
AstraZeneca
Covington
Teva
Fish and Richardson
Julphar
Johnson and Johnson
Cantor Fitzgerald
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot